Inventor · disambiguated record
Hong Wen
Also filed as: WEN HONG
5 granted patents·11 pending applications·3 citations·filing 2006–2021
68Inventor score
Top patents by PatentIndex Score
16 records- 0177US7767678B2Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the sameWYETH LLC·Filed 2006·Granted Aug 3, 2010·3 cites·21 claims
- 0261US11304907B2Pharmaceutical compositions containing a DGAT1 inhibitorNOVARTIS AG·Filed 2020·Granted Apr 19, 2022·0 cites·13 claims
- 0361US10646446B2Pharmaceutical compositions containing a DGAT1 inhibitorNOVARTIS AG·Filed 2018·Granted May 12, 2020·0 cites·8 claims
- 0458US2010113541A1Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH LLC·Filed 2009·Application pending·0 cites
- 0556US2008226714A1Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-ht1a receptor having enhanced intestinal dissolutionWYETH CORP·Filed 2008·Application pending·0 cites
- 0656US2010222334A1Pharmaceutical Formulation of ValsartanTALAMONTI WAYNE·Filed 2008·Application pending·0 cites
- 0755US7683182B2Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH LLC·Filed 2006·Granted Mar 23, 2010·0 cites·13 claims
- 0848US2013102594A1Pharmaceutical Formulation of ValsartanNOVARTIS AG·Filed 2012·Application pending·0 cites
- 0946US2023391765A1Heterobifunctional compounds as degraders of enlICAHN SCHOOL MED MOUNT SINAI·Filed 2021·Application pending·0 cites
- 1045US8445496B2Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the sameTESCONI MARC SADLER·Filed 2010·Granted May 21, 2013·0 cites·13 claims
- 1143US2013190354A1Pharmaceutical compositions containing a dgat1 inhibitorWEN HONG·Filed 2011·Application pending·0 cites
- 1243US2016374947A1Pharmaceutical compositions containing a dgat1 inhibitorWEN HONG·Filed 2016·Application pending·0 cites
- 1340US2015320687A1Pharmaceutical compositions containing a dgat1 inhibitorWEN HONG·Filed 2015·Application pending·0 cites
- 1438US2010209480A1Galenical formulations of organic compoundsALTENBURGER RALF·Filed 2008·Application pending·0 cites
- 1526US2012009257A1Galenical Formulations of a Fixed Dose Combination of Valsartan and AliskirenGHOSH INDRAJIT·Filed 2010·Application pending·0 cites
- 1625US2012003308A1Pharmaceutical Composition Comprising AliskirenBOSE SONALI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hong Wen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →